Overview
Glaucoma treatment comprises the medical, laser, and surgical interventions used to manage glaucoma, a group of progressive optic neuropathies characterised by retinal ganglion cell loss and corresponding visual field damage that, untreated, can lead to irreversible blindness. The principal modifiable risk factor and the central therapeutic target is elevated intraocular pressure, and the overarching aim of treatment is to lower and stabilise intraocular pressure to a level that halts or slows optic nerve damage and preserves vision. First-line therapy is usually pharmacological, employing topical agents that either reduce the production of aqueous humour or enhance its outflow, including prostaglandin analogues, beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, and related drug classes, used alone or in combination. When medication is insufficient or poorly tolerated, laser procedures such as trabeculoplasty and surgical options that create new drainage pathways or reduce aqueous production are used to achieve further pressure reduction. Because glaucoma is typically chronic and often asymptomatic early on, effective management also depends on timely diagnosis, regular monitoring of intraocular pressure and optic nerve function, and sustained patient adherence. Research relevant to this area examines intraocular pressure and its effects on the optic nerve and retinal function, patient awareness and literacy regarding glaucoma, and the assessment of ocular status, informing strategies to detect, treat, and monitor the disease.
Research published in this journal
9 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Rapidly Progressing Visual Loss Associated with Optic Nerve Head Drusen: Is there A Role For Lowering Intraocular Pressure?
Transiently Raised IOP Equivalent to That Experienced During Ocular Surgery Causes Moderate Inflammation but does not Affect Retinal Function or Result in Retinal Ganglion Cell Loss in An Animal Model
Influence of Visual Impairment on The Quality of Life: A Survey of Patients Reporting at The Low Vision Centre of the Eastern Regional Hospital Of Ghana
Validity of the Titmus Vision Screener: A Comparison with the Snellen Chart
Early Versus Late Immunomodulatory Therapy in Vogt-Koyanagi-Harada disease
Case Series on Chiasmal Lesions with Ocular Manifestations seen at the Eye Center of a Tertiary Government Hospital in Philippines
Resveratrol Prevents Cataract Formation by Inhibiting Pro-inflammatory Mediator-induced Dysregulation of Lens Calcium
Compression between Combined Anti-VGEF with Steroids Versus Pure Anti-VEGF in Retinal Vein Occlusion
How this research is being cited
The 9 articles above have been cited 71 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Advances in Ophthalmology and Optometry
-
2026 · European Journal of Preventive Medicine
-
2026 · British Journal of Visual Impairment
-
João Alves Ambrósio et al. · 2025 · Cureus
-
2025 · Lecture notes in networks and systems
-
2025 · Occupational Therapy In Health Care
-
2025 · World Neurosurgery
-
2025 · Lecture notes in electrical engineering
A sample of recent works citing this journal's research on Glaucoma Treatment, linking to each citing work.